Evidence map›Paper›PMID 36005442›Full record

ArticleJournal of cardiovascular development and disease2022

Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data.

Sebastian Seidl, Tanja Mülleder, Josef Kaiblinger, Stefan Sieghartsleitner, Jasmina Alibegovic-Zaborsky, Elisabeth Sigmund, Michael Derndorfer, Georg Kollias, Helmut Pürerfellner, Martin Martinek

Open access · goldAbstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sebastian SeidlDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Tanja MüllederDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Josef KaiblingerDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Stefan SieghartsleitnerDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Jasmina Alibegovic-ZaborskyDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Elisabeth SigmundDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Michael DerndorferDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.ORCID 0000-0002-0685-0845
Georg KolliasDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Helmut PürerfellnerDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Martin MartinekDepartement of Cardiology, Ordensklinikum Linz GmbH Elisabethinen, 4020 Linz, Austria.
Krankenhaus der Elisabethinen · ATBarmherzige Schwestern Krankenhaus Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCircumferential pulmonary vein isolation (PVI) using radiofrequency ablation (RFA) is a standard of care intervention for patients with symptomatic atrial fibrillation (AF). During follow-up, a substantial number of patients need a redo procedure due to reconnections on the basis of insufficient non-transmural ablation lesions. High-power short-duration ablation (HPSD) is expected to create efficient lesions while causing fewer complications than in conventional RFA settings. The aim of this study was to compare one-year outcome data of very HPSD (90 Watt, 4 s) to a strategy using 50 Watt HPSD ablation guided by the CLOSE protocol using the Ablation Index (AI), an arbitrary unit composed of power, contact force and ablation time.

methodsWe retrospectively analyzed short and long-term (median follow-up 23.2 ± 9.9 months) outcome data from 52 patients that were scheduled for first-do-symptomatic PVI. A very HPSD ablation protocol with 90 Watt and a 4 s duration cut-off was compared to an HPSD CLOSE approach (50 Watts; AI 550 at the anterior LA wall; AI 400 at the posterior LA wall, the roof and the floor) in terms of freedom from AF recurrence in a long-term electrocardiogram (ECG) over a five days surveillance period. To gain an impression of the subjective sense of wellbeing, the Atrial Fibrillation Effects on QualiTy-of-Life (AFEQT) score was recorded.

resultsOverall freedom from AF was found in 81% (90 W 4 s) vs. 87.5% (50 W), (

conclusionWithin our relatively small studied population, we found hints that in addition to shortening ablation times and radiation exposure without significantly increasing the rate of relevant intraprocedural complications, very high power short-duration ablation (90 W 4 s) provides comparable efficacy rates after one year.

Indexed as

atrial fibrillationduration ablationhigh power shortprognosispulmonary vein isolation

Identifiers

PMID36005442
PMCPMC9410376
OpenAlexW4292247282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.